ABVC BioPharma Inc. (NASDAQ:ABVC) went up by 10.09% from its latest closing price compared to the recent 1-year high of $29.95. The company’s stock price has collected 9.09% of gains in the last five trading sessions. Press Release reported 14 hours ago that ABVC BioPharma Restructures Joint Venture to Expand Access to Early-Stage Research
Is It Worth Investing in ABVC BioPharma Inc. (NASDAQ :ABVC) Right Now?
Opinions of the stock are interesting as 0 analysts out of 0 who provided ratings for ABVC BioPharma Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $9.50. ABVC currently public float of 1.81M and currently shorts hold a 11.27% ratio of that float. Today, the average trading volume of ABVC was 1.57M shares.
ABVC’s Market Performance
ABVC stocks went up by 9.09% for the week, with a monthly drop of -20.00% and a quarterly performance of -52.00%, while its annual performance rate touched -41.46%. The volatility ratio for the week stands at 6.77% while the volatility levels for the past 30 days are set at 10.21% for ABVC BioPharma Inc.. The simple moving average for the period of the last 20 days is -2.29% for ABVC stocks with a simple moving average of -44.86% for the last 200 days.
ABVC Trading at -13.83% from the 50-Day Moving Average
After a stumble in the market that brought ABVC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -91.99% of loss for the given period.
Volatility was left at 10.21%, however, over the last 30 days, the volatility rate increased by 6.77%, as shares sank -20.79% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -51.52% lower at present.
During the last 5 trading sessions, ABVC rose by +9.09%, which changed the moving average for the period of 200-days by -45.45% in comparison to the 20-day moving average, which settled at $2.42. In addition, ABVC BioPharma Inc. saw -52.94% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ABVC
Current profitability levels for the company are sitting at:
- -1760.87 for the present operating margin
- +88.44 for the gross margin
The net margin for ABVC BioPharma Inc. stands at -2026.97. The total capital return value is set at -79.11, while invested capital returns managed to touch -132.07. Equity return is now at value -566.60, with -104.20 for asset returns.
Based on ABVC BioPharma Inc. (ABVC), the company’s capital structure generated 102.62 points at debt to equity in total, while total debt to capital is 50.65. Total debt to assets is 45.85, with long-term debt to equity ratio resting at 61.85. Finally, the long-term debt to capital ratio is 30.52.
When we switch over and look at the enterprise to sales, we see a ratio of 210.22, with the company’s debt to enterprise value settled at 0.07. The receivables turnover for the company is 0.59 and the total asset turnover is 0.04. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.27.